Related Experiment Videos
CSF neuropeptide Y in alcoholics and normal controls
A Roy1, W Berrettini, J DeJong
1Laboratory of Clinical Studies, DICBR, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
Psychiatry Research
|September 1, 1990
Summary
Cerebrospinal fluid (CSF) levels of Neuropeptide Y (NPY) did not differ between male alcoholics and controls. However, NPY levels correlated positively with other neurochemicals in alcohol use disorder.
Area of Science:
- Neuroscience
- Endocrinology
- Psychiatry
Background:
- Neuropeptide Y (NPY) is a peptide found in brain tissue, implicated in stress response and potentially linked to alcoholism.
- NPY influences the hypothalamic-pituitary-adrenal (HPA) axis and is localized in catecholamine neurons, sometimes coexisting with somatostatin.
Purpose of the Study:
- To investigate potential differences in cerebrospinal fluid (CSF) Neuropeptide Y levels between male alcoholics and healthy controls.
- To explore correlations between CSF NPY levels and other neurochemicals, including corticotropin-releasing hormone (CRH), somatostatin, and growth hormone-releasing hormone (GHRH).
Main Methods:
- Comparison of CSF NPY levels in a cohort of male alcoholics and normal controls.
- Measurement of CSF levels for CRH, somatostatin, and GHRH in the same participants.
- Statistical analysis to determine group differences and identify correlations between CSF neurochemical levels.
Main Results:
- No significant difference was found in CSF Neuropeptide Y levels between male alcoholics and normal controls.
- Similarly, no significant difference was observed in CSF growth hormone-releasing hormone levels between the groups.
- Significant positive correlations were identified between CSF NPY and CSF levels of CRH, somatostatin, and GHRH.
Conclusions:
- CSF Neuropeptide Y levels do not appear to be a distinguishing biomarker for alcoholism in males based on this study.
- The positive correlations suggest a potential interplay or co-regulation of NPY with CRH, somatostatin, and GHRH in the central nervous system, possibly relevant to alcohol use disorder.